The CALHN Clinical Immunology and Allergy Team are looking for people with hereditary angioedema (HAE) to participate in a study to help increase understanding of this rare disease. HAE is a genetic condition caused by deficiency or dysfunction of the C1 inhibitor...
A research program looking into more effective treatment for those who have heart problems linked to type 2 diabetes is looking for participants. The SURPASS-CVOT study is testing the efficacy of an experimental drug, tirzepatide, in preventing cardiovascular events...
When it comes to spinal cord injury – time is critical. That’s the overwhelming message of spinal surgeon Professor Brian Freeman’s research. Among all of the studies he is involved with, reducing the time from the accident scene to the operating theatre to within 8...
A world-leading stroke trial investigating early “keyhole” brain surgery to treat acute intracerebral haemorrhage (ICH), or bleeding into the brain, is about to move to the next phase. ICH makes up about 15 per cent of all strokes and is devastating; causing around...
Medical oncologist and research director Professor Michael Brown and his team running world-leading research into helping a patient’s own immune system fight cancer. Part of the research involves taking existing drugs and making them safer and more effective. In...
